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ABSTRACT: Background: Impulsivity is common in
people with Parkinson’s disease (PD), with many devel-
oping impulsive compulsive behavior disorders (ICB). Its
pathophysiological basis remains unclear.
Objectives: We aimed to investigate local field potential
(LFP) markers of trait impulsivity in PD and their relation-
ship to ICB.
Methods: We recorded subthalamic nucleus (STN) LFPs
in 23 PD patients undergoing deep brain stimulation
implantation. Presence and severity of ICB were
assessed by clinical interview and the Questionnaire for
Impulsive-Compulsive Disorders in PD-Rating Scale
(QUIP-RS), whereas trait impulsivity was estimated with
the Barratt Impulsivity Scale (BIS-11). Recordings were
obtained during the off dopaminergic states and the
power spectrum of the subthalamic activity was ana-
lyzed using Fourier transform-based techniques.
Assessment of each electrode contact localization was
done to determine the topography of the oscillatory
activity recorded.
Results: Patients with (n = 6) and without (n = 17) ICB
had similar LFP spectra. A multiple regression model
including QUIP-RS, BIS-11, and Unified PD Rating
Scale-III scores as regressors showed a significant posi-
tive correlation between 8–13 Hz power and BIS-11
score. The correlation was mainly driven by the motor
factor of the BIS-11, and was irrespective of the pres-
ence or absence of active ICB. Electrode contact pairs
with the highest α power, which also correlated most
strongly with BIS-11, tended to be more ventral than
contact pairs with the highest beta power, which localize
to the dorsolateral motor STN.
Conclusions: Our data suggest a link between α power
and trait impulsivity in PD, irrespective of the presence
and severity of ICB. © 2021 The Authors. Movement Dis-
orders published by Wiley Periodicals LLC on behalf of
International Parkinson and Movement Disorder Society
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Cognitive and neuropsychiatric disorders are common
in people with Parkinson’s disease (PD) and have a major
impact on patients’ and caregivers’ quality of life. The
high prevalence of cognitive and neuropsychiatric disor-
ders has led to the suggestion that PD should more accu-
rately be conceptualized as a neuropsychiatric disorder.1
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Among the neuropsychiatric symptoms of PD, impul-
sive compulsive behaviors (ICB) represent a frequent
source of disability with a 5-year cumulative incidence
of 46.1%.2 ICB comprise impulse control disorders
such as pathological gambling, compulsive shopping,
hypersexual behavior, and compulsive eating, and
related disorders such as punding/hobbyism and dopa-
mine dysregulation syndrome. Interplay between expo-
sure to dopaminergic medications and endogenous
characteristics in people with PD seem to underlie the
generation of these behavioral disorders.3 In particular,
certain personality traits have been suggested to predis-
pose people with PD to develop ICB, namely a novelty
seeking profile and high level of impulsivity.4,5 Impul-
sivity has been conceptualized as a multifactorial con-
struct accounting for at least three dimensions: trait
impulsiveness, impulsive action, and impulsive choices.6
Clinical and experimental evidence suggests that the
subthalamic nucleus (STN) plays a key role in
the inhibitory control of both action and behavior.7
The STN is also the main target of deep brain stimula-
tion (DBS), a well-recognized effective treatment for
people with advanced PD. STN-DBS can provide the
opportunity to record STN local field potentials (LFPs)
and such recordings have provided important informa-
tion on the pathophysiology of motor features of PD
and the effects of treatment with levodopa. However,
relatively little is known about the LFP correlates of
non-motor symptoms in PD and in particular ICB. An
influential resting state study reported greater theta
band activity in the ventral STN in PD with active ICB
in the “on medication” condition,8 but the extent to
which this might reflect trait differences as opposed to a
particular neural circuit response to levodopa medica-
tion remains unclear. Indeed, to date, no studies have
investigated the electrophysiological markers of trait
impulsivity, which might predispose patients to ICB.
Accordingly, here, we evaluate the LFP correlates of
trait impulsivity in a cohort of PD patients with and
without ICB, assessing trait impulsivity with the Barratt
Impulsivity Scale (BIS-11), a validated and widely used
scale.
Methods
Patients and Clinical Assessments
Consecutive PD patients undergoing bilateral STN-
DBS who gave their written informed consent to partic-
ipate in the experiment (IRAS project ID: 75154) were
recruited at St. George’s University Hospital, London,
United Kingdom (UK).
Motor symptoms were assessed before DBS (205
+ 61 days before) and included a levodopa challenge
test as per Core Assessment Program for Surgical Inter-
ventional Therapies in PD (CAPSIT-PD) protocol with
rating of Unified Parkinson’s Disease Rating Scale part
III (UPDRS-III) in the practically defined off and on
medication state.9 Presence and severity of dyskinesia
were evaluated with the UPDRS-IV (total score and
sum of sub-items 32–35 for dyskinesia) and the Rush
Dyskinesia Rating Scale (RDRS). The diagnosis of ICB
relied on a semi-structured interview based on
ICB diagnostic criteria,10 which was performed on the
same day as the levodopa challenge test and confirmed
at the time of the study. ICB was defined as “Active” if
it was ongoing at the time of study entry. “Past” ICB
were defined as patients who had ICB at any point dur-
ing their disease, but were in remission at the time of
the study. The Questionnaire for Impulsive-Compulsive
Disorders in PD-Rating Scale (QUIP-RS)11 and BIS-
1112 were used to measure severity of ICB and trait
impulsivity, respectively. The BIS-11 scale is a 30-item
questionnaire measuring trait impulsivity, comprising
the following factors: attentional (attention and cogni-
tive instability), motor (motor and perseverance), and
non-planning (self-control and cognitive complexity).
Presence and severity of depression was evaluated with
the Hamilton depression rating scale (HDRS).
Neurophysiological Testing
DBS implantation was a staged procedure. LFP
recordings were made between 3 and 5 days postopera-
tively, while electrode leads were still externalized and
before implantation of the subcutaneous pulse genera-
tor. Patients were recorded OFF medication.
LFP recordings were made for a minimum of
3 minutes (maximum 10 minutes) while patients were
seated comfortably at rest in an armchair with their
eyes open. Signals were recorded with a TMSi-Porti
amplifier (TMS International, Oldenzaal, the Nether-
lands). The ground electrode was placed on a forearm.
LFP signals were sampled at 2048 Hz and common
average referenced. LFPs from quadrapolar electrodes
were offline reconfigured to give a bipolar contact
arrangement between the four levels so that each elec-
trode afforded three bipolar signals on the left (from
bottom to top: L01, L12, L23) and right (R01, R12,
R23). In 17 patients, directional leads (15 Boston Scien-
tific and 2 Abbott Neuromodulation) were implanted
and directional contacts of one level were connected
together to form one “ring” contact, and then bipolar
contacts were constructed offline as before. Note that
the contributions of the three segmented contacts to the
ring contact average may not be equal considering that
impedances may have differed between the segmented
contacts, although the latter have similar dimensions.
In one patient (case 16) the lead was a non-
directional octopolar one and we selected the four most
ventral electrodes per side, after checking that they were
located adjacent to or in the STN. In one patient (case
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7) we excluded one channel (R23) because of the pres-
ence of artifacts. Bipolar montages between adjacent
contact pairs were used because they limit the effects of
volume conduction from distant sources.13
The data were first visually inspected using Spike2
Software (CED Cambridge Electronic design limited,
UK). Sections contaminated by artifacts (eg, signal satu-
ration or movement artifact) were removed from the
data set. The average duration of analyzed artifact-free
data was 262  161 seconds. For the main analysis
LFP activity in the STN region was computed by aver-
aging across all bipolar channels of each electrode to
avoid any channel selection bias. Spectral analysis
based on the fast Fourier transform was performed in
Spike2. Non-overlapping windows of 2048 data points
were analyzed, affording a spectral resolution of 1 Hz.
LFP power at frequencies ≤4 Hz was excluded from
further analysis, because this is subject to movement
artifacts and heavily influenced by the 1/f nature of the
signal rather than by oscillations. We considered power
between 5–35 Hz as our range of interest because it
includes the θ-α band previously implicated in ICB8 and
the β band associated with motor impairment, but also
implicated in response inhibition in some studies. Power
in this range of interest was normalized by dividing it
by the sum of the power over 5–395 Hz (excluding line
noise peaks at 50  5 Hz and its harmonics) and multi-
plying by 100 to give a percentage. This step is neces-
sary to limit the variation in spectral power between
sides and subjects because of variance in targeting and
impedance.
Additional information is in the Supporting Data.
Statistical Analysis
In our core analysis, we used a general linear model
(GLM) to investigate if STN power averaged across all
contacts and the left and right hemispheres was signifi-
cantly related to ICB severity (QUIP-RS) and trait
impulsivity (BIS-11). To assess if motor symptoms
accounted for variations in the LFP we also added the
UPDRS-III scores to the GLM. The predictor variables
were z-transformed to enable a better comparison of
the regression coefficients. The model was fitted using
the MATLAB function fitlm with a bisquare weighting
function to compute a robust fit (v. 2019b, The
MathWorks, Natick, MA). Regression coefficients were
computed separately for frequencies ranging from 5 to
35 Hz and corrected for multiple comparisons with a
cluster-based permutation procedure described in the
Supporting Data.
In subsequent exploratory analyses we took the aver-
age power over the 8–13 Hz frequency range found to
be significant using the above approach and determined
its relationship with the three components of the BIS-11
captured by the attentional, motor and non-planning
sub-scores, and with the HDRS score. Spearman’s cor-
relation coefficients were computed to compare the size
of correlations. STN power was averaged across the left
and right hemispheres in each subject before the corre-
lation analysis unless otherwise stated. Finally, we
determined the relationship between α power and BIS-
11 scores when extracting power from the bipolar con-
tact configuration that had the highest α power and
contrasted this with that from the contact pair with the
highest β power.
Results
We evaluated 23 PD patients undergoing STN-DBS
(five women, mean age 59.0  6.2 years, mean disease
duration 9.8  3.7; Table 1). According to the semi-
structured clinical interview, six patients had active ICB
and 17 had no-active ICB. Demographic and clinical
differences between these subgroups are summarized in
Table 2. Within the no-active ICB group seven patients
had ICB in the past, whereas 10 patients had never had
any ICB.
Dependencies between LFP Power and
Symptom Complexes
To explore statistical dependencies between LFP
power over the 5–35 Hz range and behavioral features,
we computed a multiple regression model including the
QUIP-RS score, BIS-11 score, and UPDRS-III score as
predictors and LFP power as outcome variable. We
found significant positive regression coefficients for LFP
power estimates between 8–13 Hz and BIS-11 score
after correcting for multiple comparisons over the
whole 5–35 Hz frequency range with the cluster-based
permutation procedure (Fig. 1A). Although the active
ICB group had a power peak in the low β frequency
range, which was not present in the no-active ICB
group (Fig. 2), the regression analysis did not result in a
significant cluster in this frequency band.
Neither the coefficients for the QUIP-RS or UPDRS-
III score were significant in this model after correction
for multiple comparisons, although those for the
UPDRS-III did show a peak in the low β range.
This dependency between α power and BIS-11 score
was confirmed in a model with power averaged across
8–13 Hz as outcome variable (F-statistic = 4.21,
P = 0.019; BIS-11: t-statistic [t-stat] = 3.17, P = 0.005;
QUIP-RS: t-stat = 0.07, P = 0.942; UPDRS: t-
stat = 0.55, P = 0.589). Therefore there was a link
between STN oscillatory activity in the α range and
impulsivity, independent of motor symptoms and the
severity of ICB. To visualize this relationship, we corre-
lated 8–13 Hz power with the BIS-11 scores across
patients (Spearman’s ρ = 0.67; Fig. 1B). To test if the
diagnosis of active ICB played a role in influencing
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the correlation, we computed another regression model
with “active ICB”/“no-active ICB” as categorical vari-
able, age, and the total BIS-11 score as predictors.
Again, only the coefficient for the BIS-11 scores was
significant (BIS-11: t-stat = 2.81, P = 0.011; active/no-
active ICB: t-stat = 0.59, P = 0.562, age: t-stat = 0.15,
P = 0.884, interaction BIS-11*active/no-active: ICB t-
stat = 0.65, P = 0.525).
The lack of significance of the active ICB diagnosis
variable (t-stat = 0.587, P = 0.564) and lack of inter-
action (t-stat = 0.723, P = 0.5), together with the sig-
nificant BIS-11 t-statistic (t-stat = 3.04, P = 0.007)





















01 60 8 Medtronic
3389
L 970 320 28 8 Active ICB Compulsive
shopping,
hypersexuality
02 60 15 DB-2202 R 1563 315 50 30 Past ICB
03 60 6 Medtronic
3389
L 800 0 48 14 Past ICB
04 60 13 DB-2202 L 1403 280 77 27 past ICB
05 47 16 DB-2202 R 865 0 71 37 past ICB
06 53 7 DB-2202 L 635 160 38 25 Active ICB Hypersexuality,
compulsive eating,
punding
07 55 16 Medtronic
3389
R 1810 360 51 19 Never ICB
08 65 15 Medtronic
3389
L 666 0 57 34 Never ICB
09 52 7 DB-2202 L 1152 180 18 1 Active ICB Hypersexuality,
compulsive
shopping
10 66 9 DB-2202 R 1124 360 52 30 Never ICB
11 65 5 Medtronic
3389
R 995 320 34 16 Never ICB
12 48 7 DB-2202 R 1180 0 45 34 Active ICB Pathological gambling
13 61 10 DB-2202 R 500 0 33 12 Past ICB
14 51 12 DB-2202 L 1020 320 27 13 Active ICB Hypersexuality
15 56 6 DB-2202 R 1380 480 48 19 Past ICB
16 66 6 Bsci octode L 580 0 17 11 Never ICB
17 67 7 AB-6170 L 820 320 17 5 Never ICB
18 62 6 DB-2202 R 1082 300 42 13 Never ICB
19 64 12 DB-2202 L 160 160 52 21 Active ICB Compulsive shopping
20 63 10 DB-2202 R 780 80 40 17 Never ICB
21 63 10 AB-6170 R 1800 375 41 11 Past ICB
22 52 11 DB-2202 L 1470 160 54 27 Never ICB
23 63 10 DB-2202 R 1275 300 29 10 Never ICB
Abbreviations: D-Ag, dopamine-agonists; F, female; ICB, impulsive compulsive behavior disorders; L, left; LEDD, levodopa equivalent daily dose; M, male; R, right; y, years;
UPDRS-III, Unified Parkinson’s disease rating scale; Implanted leads, Medtronic 3389, (Medtronic, Minneapolis, USA) four 0.5-mm spaced contacts of 1.5-mm length with
platinum-iridium cylindrical surfaces; DB-2202, directional leads from Boston Scientific with three segmented contacts on the middle levels (Boston Scientific, USA); Bsci
octode, octopolar non directional leads from Boston Scientific; AB-6170, directional leads from St. Jude Medical with three segmented contacts on the middle levels (model
6170, Abbott Neuromodulation, Austin, TX, USA).
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highlights that the correlation between BIS-11 and α
power was present irrespective of the presence of
active ICB. The three PD subgroups (Never ICB, Past
ICB, and Active ICB) are highlighted in red, blue, and
black in Fig. 1B. It shows that a positive relationship
was present within each subgroup (Never ICB:
ρ = 0.48, P = 0.160 [n = 10]; Past ICB: ρ = 0.79,
P = 0.048 [n = 7]; Active ICB: ρ = 0.83, P = 0.058
[n = 6]). The relationship was only significant in the
Past ICB group, but the number of patients in each
subgroup was small. Example spectra of two patients,
one with a low and one with a high BIS score, are
shown in Figure 1C.
Then we performed a series of exploratory correla-
tions aimed at refining the link between α activity and
the BIS-11 score. Impulsivity is thought to comprise
three components dissociable as the attentional, motor,
and non-planning second-order factors in the BIS-11.
Accordingly, we correlated each of these BIS-11 sub-
scores with the normalized LFP power averaged over
the 8–13 Hz frequency bins. Alpha power correlated
most strongly with the motor component sub-score
(ρ = 0.61, P = 0.002, unadjusted and significant after
Holm-Bonferroni correcting for multiple comparisons),
followed by the attentional sub-score (ρ = 0.53,
P = 0.010), although the latter was also correlated with
the motor component sub-score (ρ = 0.67, P < 0.001,
significant after multiple comparison correction). The
non-planning component was the most weakly corre-
lated with α power (ρ = 0.42, P = 0.047), and also did
not correlate significantly with the motor
subcomponent (ρ = 0.14, P = 0.518). Given the corre-
lation between the motor and attentional subcompo-
nents, we performed partial correlations between the
BIS-11 motor sub-score and α power while controlling
for attention (ρ = 0.39, P = 0.072) and, conversely,
between the BIS-11 attention sub-score and α power,
controlling for the motor sub-score (ρ = 0.19,
P = 0.400).
We also performed partial correlations between α
power and BIS-11 controlling for: depression, dopami-
nergic therapy (total levodopa equivalent daily doses
[LEDD] and LEDD dopamine-agonists) and dyskinesia
severity. The correlation remained high (HDRS:
ρ = 0.70, P = 0.001, n = 21 instead of 23, because for
two patients the depression scores were not recorded;
total LEDD: ρ = 0.67, P = 0.001; LEDD dopamine-
agonists: ρ = 0.67, P = 0.001; UPDRS-IV dyskinesia
sub-scores: ρ = 0.65, P = 0.001; RDRS scores:
ρ = 0.67, P = 0.001). Together these results suggest
TABLE 2 Comparison between PD ICB active and PD-no-active ICB for demographic and clinical data
PD no ICB PD ICB P-value
Age (y) 60.6  5.4 54.6  6.0 0.05
Disease duration (y) 10.0  3.8 8.8  2.5 0.7
Total LEDD (mg) 1112.5  410.8 852.8  391.3 0.3
Dopamine-agonists LEDD (mg) 214.7  166.0 190  119.8 0.7
UPDRS-III off med 44.7  16.1 34.6  12.6 0.1
UPDRS-III on med 19.5  9.4 17  12.0 0.6
UPDRS-IV total 5.5  2.0 4.8  3.3 0.3
UPDRS-IV dyskinesia sub-score 1.6  1.4 1.8  2.2 0.8
RDRS 3.4  2.4 4.4  4.3 0.8
QUIP-RS total score 11.3  15.0 37  17.4 a0.003
QUIP-RS ICD score 5.8  7.8 20.1  8.6 a0.004
BIS-11 total score 57.1  10.3 63.3  10.1 0.2
BIS-11 attention 13.2  3.1 17  3.8 a0.04
BIS-11 motor 21.2  4.1 22.5  1.9 0.3
BIS-11 nonplanning 22.6  6.9 23.8  5.3 0.5
HDRS 6.0  5.1 6.5  6.2 0.8
Values are means  SD.
aSignificant at P < 0.05 (uncorrected for multiple comparisons).
Abbreviations: BIS-11, Barratt impulsivity scale; F, female; ICB, impulsive compulsive behavior disorders; ICD, impulse control disorders; HDRS, Hamilton Depression Rating
Scale; LEDD, levodopa equivalent daily dose; M, male; QUIP-RS, Questionnaire for Impulsive-Compulsive Disorders in PD-Rating Scale; RDRS, Rush dyskinesia rating scale;
UPDRS-III, Unified Parkinson’s disease rating scale-motor part; UPDRS-IV, UPDRS complications of therapy part; UPDRS-IV dyskinesia sub-score, sum of items 32–35.
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that the correlation between BIS-11 and α power is
dominated by the correlation between the motor impul-
sivity component and α power.
Source of the LFP Activity Correlating with Trait
Impulsivity
We found no evidence of lateralization when correlat-
ing the BIS-11 score with the average normalized 8–
13 Hz LFP power obtained from two subsets (left and
right) of contacts obtained in the two hemispheres
(Supporting data). Averaging these two subsets again
confirmed the significant relationship between alpha
power and BIS-11 scores (averaged between hemi-
spheres [n = 23]: ρ = 0.61, P = 0.002).
Contacts were located predominantly in the postero-
lateral “motor STN,” as shown by the distribution of α
power within the recorded region of the STN (Fig. 3).
A hotspot is seen that is inset from the postero-lateral
border of the STN by approximately a quarter of the
distance between the nucleus’ poles. Another way of
determining whether the α band signal correlating with
the BIS-11 comes primarily from the motor STN or
not, is to contrast the correlations established above
with correlations based on α power from the bipolar
contacts that had the highest β (rather than alpha)
FIG. 1. Multiple linear regression with STN power averaged across all bipolar signals as criterion and BIS-11, QUIP-RS, and UPDRS-III scores as pre-
dictors. (A) A significant cluster (see red crosses) was found between 8–13 Hz power for the BIS-11 scores, indicating a positive relationship between α
power and the strength of impulsivity (n = 23). The t-scores for the UPDRS-III predictor showed a positive deflection in the high β range, but the effect
did not survive correction for multiple comparisons. An exploratory correlation with just contralateral hemibody bradykinesia and rigidity items was sig-
nificant over 31–32 Hz (inclusive): ρ = 0.44, P = 0.035. Gray shadow in upper panels shows the standard error of the coefficients. (B) Scatter plot of
BIS-11 scores and 8–13 Hz α power averaged across all bipolar contacts. The three different colors of the points denote whether ICB were currently,
previously or never present (red, active; blue, past; black, never). (C) Example STN LFP power spectra. Left-hand and right-hand sets of six panels
come from patients with a high BIS-11 score of 78 and a low BIS-11 score of 49, respectively. Y-axes showing normalized power have been optimized
to view the α band activity shown between the two vertical dashed lines. Each set of six panels shows the spectra recorded at the three bipolar con-
tacts (01, 12, and 23) on the left (L) and right (R) sides. Contact 0 is the most ventral on each side. [Color figure can be viewed at
wileyonlinelibrary.com]
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power per electrode. This is because the bipolar contact
with the highest β power tends to localize to the dorsal
posterolateral “motor” STN.14 Use of the highest β con-
tact pair led to weakening of the relationship between α
power and BIS-11 scores (averaged between hemi-
spheres [n = 23]: ρ = 0.37, P = 0.080; compared to
ρ = 0.61, P = 0.002 for peak α contacts). This
suggested that the source of the α power that correlates
best with BIS-11 scores may be slightly different to the
β power hotspot in the motor region of the STN.
Indeed, the relationship between the different sets of
contact pairs supported a slightly more ventral source
for the peak α activity that maximally correlates with
the BIS-11 score. The bipolar contact with the highest α
power (and the stronger α-BIS correlations) was ventral
in 21 of 46 (46%) instances, overlapping in 17 of
46 (37%) instances and dorsal only in 8 of 46 (17%)
instances when compared with the bipolar contact with
the highest β power.
Discussion
This is the first study in people with PD to explore
STN LFP correlates of trait impulsivity per se. We
recorded LFPs at rest in the “off medication” condition
and found a positive correlation between the oscillatory
activity in the α band (8–13 Hz) and the degree of trait
impulsivity in PD patients, irrespective of the presence
and severity of active ICB. STN LFP power spectra
showed no significant differences between patients with
and without active ICB.
Trait Impulsivity Is Separate from ICB
The relationship between impulsivity and ICB is com-
plex and still not very clear. Indeed, impulsivity is
common in PD, even in the absence of ICB. It is a psy-
chological construct characterized by poor control of
thoughts and actions with a tendency to rapidly
respond to impulses and environmental cues despite
potential negative consequences. Therefore impulsivity
itself has obvious aspects in common with ICB, and
indeed previous studies have shown high trait impulsiv-
ity (ie, a high score on the Barrat-11 scale) in PD
patients with ICB. However, there is no evidence on
whether this is a specific component of ICB or a
predisposing factor that might be present in a number
of these patients.4,15 Moreover, clinical studies looking
at differences in impulsivity between PD patients with
and without ICB have reported inconsistent results
with higher4,15,16 or comparable levels of trait impulsiv-
ity measured by BIS-11.17 Behavioral aspects of
impulsivity, such as action and choice impulsivity have
also been studied in relation to ICB, again with
inconsistent findings. Indeed, on behavioral testing, the
presence of ICB in PD have been associated with
increased impulsivity,5,18,19 less impulsivity,20,21 or no
difference compared to PD without ICB.22,23 Our data
expand this previous literature and suggest that ICB,
encompassing compulsive components, do not necessar-
ily share the same alterations of neural activity as
underlie trait impulsivity. Hence, patients may exhibit
the two behavioral phenomena to different degrees, and
trait impulsivity can be present even in the absence of
FIG. 2. The power spectra of Active (n = 6) and NoActive (n = 17) ICB
patients showed no significant differences. Statistics were computed
using a non-parametric cluster-based permutation procedure. Shaded
regions show standard errors. [Color figure can be viewed at
wileyonlinelibrary.com]
FIG. 3. Distribution of α power. Power averaged across contact posi-
tions normalized relative to the STN poles (anterior pole: x = 0.5,
y = 0.5; posterior pole: x = 0.5, y = 0.5), reducing the between-sub-
jects variability because of differently sized subhalamic nuclei. Dis-
tances are relative to the STN centroid located at [0, 0], where the
horizontal and vertical lines cross. The black ovoid represents the
dimensions of the idealized STN. Note that contacts were positioned
such that not all of the STN was covered. [Color figure can be viewed at
wileyonlinelibrary.com]
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ICB. Finally, the demonstration of a physio-marker for
trait impulsivity described here would provide the
opportunity to assess its modulation by short and long-
acting dopaminergic medications and correlation to
ICB change using novel sensing DBS devices.
Relationship to Other LFP Studies
Previous LFP studies in PD patients have reported a
modulation of low frequency activity in the α-θ band
during tasks assessing inhibitory control of action as a
proxy of impulsivity, such as the stop-signal, Stroop
and Flanker tasks.24 These results support the role of
STN and low frequencies in modulating action and
choice inhibition in PD. However, whether impairments
in these tasks are relevant in the generation of behav-
ioral and affective symptomatology is unclear.
Only two studies have specifically carried out LFP
recordings in the STN in PD patients focusing on ICB.
Rodriguez-Oroz et al8 reported θ activity in the ventral
region of STN in ICB in the on medication condition.
In addition, Rosa et al25 demonstrated that PD patients
with pathological gambling, a specific type of ICB,
adopted a risky strategy during decision making and
showed a greater change in low-frequency power in the
STN when evaluating trials with conflict compared to
those without. Like Rodriguez-Oroz et al,8 we found
no difference between PD with and without ICB in LFP
patterns recorded in the “off medication” condition,
suggesting perhaps that the differences they identified
on medication might reflect a specific neural circuit
response to dopaminergic stimulation in ICB.
Impulsivity is a multi-faceted construct and this multi-
dimensionality is reflected in the BIS-11 factor structure.
Our data suggest that the positive correlation between α
power and BIS-11 scores was mostly driven by the second
order motor factor rather than by the non-planning or
attentional factors of the BIS-11. Both mapping of the α
power distribution in space across subjects and along the
electrode within subjects raised the possibility that α
power correlating with the BIS-11 tends to arise from an
area slightly ventral to the dorsolateral motor area. This
is consistent with higher resolution microelectrode record-
ings, which identify a region more ventral to the motor
area that is characterized by 7–10 Hz activity.26
The dominant correlation between α power and the
BIS-11 motor factor is also consistent with a recent
structural connectivity study that associates impulsivity
in PD to STN connectivity, with the response inhibition
or “stopping” network linking left supplementary area
and right inferior frontal gyrus.27 This network is
thought to involve hyperdirect pathway input to the
STN,28 with the strength of hyperdirect connections
correlating with the efficacy of stopping.29,30
Impulsivity is a key component in a number of other
neuropsychiatric disorders, and it is therefore
interesting that, among these, elevated α band power at
rest has been reported in the ventralis oralis complex of
the thalamus of patients with Tourette’s syndrome,31 in
the bed nucleus of stria terminalis or in subgenual cin-
gulate area in patients with major depression,32 and in
the nucleus accumbens in patients with addiction or
substance use disorders.33 This raises the possibility
that α activity might serve as a biomarker for behav-
ioral impulsivity across neuropsychiatric disorders.
Study Limitations
First, our sample included six patients with active
ICB; hence, the absence of state-dependent differences
in STN LFPs may have been a type 2 error, particularly
because group differences might have been attenuated
by a post-operative stun effect. Second, although our
data demonstrate that α power and trait impulsivity are
correlated, they cannot ascertain whether this reflects a
primarily pathological or a secondary, possibly com-
pensatory, process. Third, the precision of our neuro-
surgical targeting meant that we could not sample
directly from the ventromedial limbic and associative
parts of the STN. Fourth, previous LFP studies in PD
have shown a correlation between the reduction in α
power in the STN in response to emotionally charged
stimuli and depression.34,35 However, we controlled for
the role of depression when assessing the relationship
between resting α power and trait impulsivity and
showed that the relationship was independent from the
severity of depression. We also controlled for total
LEDD and LEDD dopamine-agonists considering that
dopaminergic therapy can enhance impulsivity, and
controlled for the severity of dyskinesia as previous
studies found an association between dyskinesia and
increased α-θ power in the on medication condition.8,36
We showed that the relationship between BIS-11 and α
activity remained strong even after controlling for these
factors, perhaps because our recordings were only car-
ried out in the off-medication condition. However, because
dopaminergic therapy has a key role in triggering ICB in
PD patients with predisposing factors, future studies with
LFP recordings on and off medication are warranted to
further explore the complex relationship between trait
impulsivity, ICB, and dopaminergic medication.
Moreover, we acknowledge that our recordings were
carried out only in the off-medication condition, because
dopaminergic therapy has a key role in triggering ICB in
PD patients with predisposing factors, future studies with
LFP recording on and off medications are encouraged to
further shade light on the complex relationship between
trait impulsivity, ICB, and dopaminergic medications.
We normalized the spectra relative to a very broad fre-
quency range spanning 5–395 Hz to minimize the contri-
butions of other physiological or pathological peaks such
as those in the β range. In addition, it is possible that our
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frequency range of interest, 8–13 Hz, was influenced by
the tail of any peaks in the low-β power range. On the
other hand, this frequency range was objectively defined
as that showing significant correlation with impulsivity in
a sweep of all frequencies from 5–35 Hz.
Finally, clinical assessments predated LFP recordings,
which might have weakened the behavioral correlations
and might, together with the use of the total UPDRS III
score, help explain the LFP correlations with motor
impairment compared to those previously reported.37,38
In conclusion, we show a positive correlation
between α power and trait impulsivity in PD patients
with and without ICB. Our findings motivate further
investigation of α power in PD and other conditions
characterized by impulsivity and suggest that this spec-
tral feature might serve as a neural biomarker that
relates to impulsive behavior.
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